Skip to content

Investigating the effect of Oral capsule of Ziziphora tenuior plant extract on Primary Dysmenorrhoea

Investigating the effect of Oral capsule of Ziziphora tenuior plant extract on Primary Dysmenorrhoea

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240506061675N1
Enrollment
94
Registered
2024-05-26
Start date
2024-06-08
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea.

Interventions

Intervention 1: Intervention group: In this study, the intervention group consumes the oral capsule of Ziziphora tenuior plant extract. In this research, the Ziziphora tenuior plant was collected from

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Have no children Participants must be between the ages of 18 and 30. Be Iranian According to the statement of the person suffering from a known chronic disease such as Diabetes, Hypertension, Underlying heart disease, Infectious disease, liver disease, kidney disease, Epilepsy and Malignancy She has not taken any medication since three months before the intervention. Do not use special drugs or supplements According to the person's statement, she does not have any symptoms such as burning, itching or abnormal secretions from the Vagina and Cervix Have regular cycles from 22 to 35. Body mass index should be between 19.8 and 26. Have a history of primary dysmenorrhoea according to the Visual analog scale during the last 6 months Students living in Shahid Beheshti Medical Sciences student dormitories in Tehran The amount of bleeding should be between 3 and 7 days No bleeding between periods. There should be no stressful events such as the death of relatives and surgery in the last 6 months. Do not smoke or drink alcohol. There is no history of Uterine disorders (Myoma, Bicornuate uterus, Polyps), Ovarian disorders (Ovarian Cyst and Polycystic ovary) or Endometrial hypertrophy and Endometriosis according to recent ultrasounds.

Exclusion criteria

Exclusion criteria: Take any herbal medicine while studying. Participants do not want to continue treatment. Kidney or liver disease or cases that, according to the doctor's opinion, should stop treatment, appear during the research. Failure to correctly use Ziziphora tenuior capsules or placebo, less than 7 capsules in the first three days of menstruation.

Design outcomes

Primary

MeasureTime frame
Primary dysmenorrhea. Timepoint: before the intervention and after the end of the intervention, after each menstrual cycle in two consecutive cycles. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Systemic symptoms associated with primary dysmenorrhea. Timepoint: Before the intervention and after the end of the intervention, after each menstrual cycle in two consecutive cycles. Method of measurement: Verbal multidimensional scoring system.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Azarialikhanghaleh

Shahid Beheshti University of Medical Sciences

fateme.azari@sbmu.ac.ir+98 21 8877 9546

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026